Eileen Boyle, MD, PhD, University College London, London, UK, briefly describes how the novel dynamic PANGEA model aims to improve risk assessment in patients with smoldering multiple myeloma (SMM) at a high risk of progression to multiple myeloma. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.